RxDoctor Payments Data

Nicholas van Benschoten, DO

Family Medicine · Cincinnati, OHNPI 1659908275

Payments from drug & device makers

$1,128in general payments, 2019–2025

Across 46 payments — averaging $24.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$268
  • Novo Nordisk$262
  • Boehringer Ingelheim$158
  • AbbVie$154
  • Dexcom, Inc.$65
  • Exact Sciences$56
  • plus $164 from 9 others

What the payments were for

  • Food & beverage$1,128100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,128 in reported general payments places this provider in the 65th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$64,546
Medicare patients
179
Services billed
856

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide56$66,147
TrulicityDulaglutide44$55,942
EliquisApixaban38$48,656
JardianceEmpagliflozin27$46,552
FarxigaDapagliflozin Propanediol24$23,770
MounjaroTirzepatide11$11,625
ArexvyRsvpref3 Antigen/As01e/Pf17$4,889
Duloxetine Hcl31$2,453
Atorvastatin Calcium360$2,352
Rosuvastatin Calcium166$2,080
Albuterol Sulfate HfaAlbuterol Sulfate43$1,644
Gabapentin59$1,044
Bupropion XlBupropion Hcl45$924
Tamsulosin Hcl87$916
Lisinopril154$822

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$268$67,56655 claims
Novo NordiskOzempic$262$66,14756 claims
PfizerEliquis$22$48,65638 claims
Boehringer IngelheimJardiance$158$46,55227 claims
AstraZenecaFarxiga$13$23,77024 claims
GSKArexvy$19$4,88917 claims
AbbVieSynthroid$154$50317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →